Preoperative and postoperative care of patients after MitraClip and TriClip procedures: modern approaches and best practices

    Authors

    Keywords

    minimally invasive procedures, mitral regurgitation, tricuspid regurgitation, quality of life

    DOI

    https://doi.org/10.15836/ccar2025.293

    Full Text

    MitraClip and TriClip are minimally invasive percutaneous procedures used to treat mitral and tricuspid regurgitation (1). MitraClip addresses severe mitral regurgitation, while TriClip targets tricuspid regurgitation. Both interventions reduce blood backflow through the affected valves and improve cardiac function. These procedures are particularly beneficial for patients who are not candidates for conventional surgery, offering reduced invasiveness, shorter recovery, and lower risk of complications (1). Preoperative care involves detailed medical history, laboratory and diagnostic tests, cardiac function assessment, and psychological preparation. Special attention is given to anesthesiologic evaluation and the placement of venous catheters. Postoperative care begins with intensive care unit monitoring, including vital signs, therapy administration, and observation for complications such as arrhythmia, bleeding, or infections. After stabilization, patients return to the cardiology ward for continued monitoring of valve function, intervention site care, and therapy. Early mobilization is initiated within 24 hours, and outpatient follow-up and therapy continue after discharge. These minimally invasive procedures significantly improve patients’ quality of life, reduce symptoms, prolong survival, and represent a modern, safe, and effective approach to the treatment of valvular heart disease.

    Literature

    1. Adamo M, Chioncel O, Benson L, Shahim B, Crespo-Leiro MG, Anker SD, et al. Prevalence, clinical characteristics and outcomes of heart failure patients with or without isolated or combined mitral and tricuspid regurgitation: An analysis from the ESC-HFA Heart Failure Long-Term Registry. Eur J Heart Fail. 2023 July;25(7):1061–71. https://doi.org/10.1002/ejhf.2929
    Cardiologia Croatica
    Back to search

    Preoperative and postoperative care of patients after MitraClip and TriClip procedures: modern approaches and best practices

    Extended Abstract
    Issue11-12
    Published
    Pages293
    PDF via DOIhttps://doi.org/10.15836/ccar2025.293
    minimally invasive procedures
    mitral regurgitation
    tricuspid regurgitation
    quality of life

    Authors

    Ivana Branilović*ORCIDUniversity Hospital Centre Zagreb, Zagreb, Croatia
    Monika RadićORCIDUniversity Hospital Centre Zagreb, Zagreb, Croatia
    Lucija KaramatićORCIDUniversity Hospital Centre Zagreb, Zagreb, Croatia

    *Correspondence email: ivana.martinovic20@gmail.com

    Full Text

    MitraClip and TriClip are minimally invasive percutaneous procedures used to treat mitral and tricuspid regurgitation (1). MitraClip addresses severe mitral regurgitation, while TriClip targets tricuspid regurgitation. Both interventions reduce blood backflow through the affected valves and improve cardiac function. These procedures are particularly beneficial for patients who are not candidates for conventional surgery, offering reduced invasiveness, shorter recovery, and lower risk of complications (1).

    Preoperative care involves detailed medical history, laboratory and diagnostic tests, cardiac function assessment, and psychological preparation. Special attention is given to anesthesiologic evaluation and the placement of venous catheters. Postoperative care begins with intensive care unit monitoring, including vital signs, therapy administration, and observation for complications such as arrhythmia, bleeding, or infections. After stabilization, patients return to the cardiology ward for continued monitoring of valve function, intervention site care, and therapy. Early mobilization is initiated within 24 hours, and outpatient follow-up and therapy continue after discharge.

    These minimally invasive procedures significantly improve patients’ quality of life, reduce symptoms, prolong survival, and represent a modern, safe, and effective approach to the treatment of valvular heart disease.

    Literature

    1. 1.
      Adamo M, Chioncel O, Benson L, Shahim B, Crespo-Leiro MG, Anker SD, et al. Prevalence, clinical characteristics and outcomes of heart failure patients with or without isolated or combined mitral and tricuspid regurgitation: An analysis from the ESC-HFA Heart Failure Long-Term Registry. Eur J Heart Fail. 2023 July;25(7):1061–71.DOI